Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Sell Sage Group (SGE) by Canaccord Genuity
- Buy Michelmersh Brick Holdings (MBH) by Canaccord Genuity
- Buy B&M European Value Retail S.A. (DI) (BME) by Canaccord Genuity
- Neutral Anglo American (AAL) by JP Morgan
- Underweight Antofagasta (ANTO) by JP Morgan
- Overweight Fresnillo (FRES) by JP Morgan
- Overweight Hochschild Mining (HOC) by JP Morgan
- Outperform Breedon Group (BREE) by RBC Capital
- Buy LBG Media (LBG) by Shore Capital
- Buy DFS Furniture (DFS) by Jefferies
- Buy Balfour Beatty (BBY) by Deutsche Bank
- Buy Helios Underwriting (HUW) by Deutsche Bank
- Buy Jet2 (JET2) by Deutsche Bank
- Hold Sage Group (SGE) by Deutsche Bank
- Buy SSE (SSE) by HSBC
- Hold WPP (WPP) by HSBC
- Buy Flutter Entertainment (DI) (FLTR) by Goldman Sachs
- Buy Sage Group (SGE) by Citi
- Buy B&M European Value Retail S.A. (DI) (BME) by Citi
- Buy Clarkson (CKN) by Berenberg
Sareum Holdings (SAR) Share Price
Health Care Sector
NOTE: This is based on 3 open tips for Sareum Holdings (SAR)
| Latest Bid : 25.00p | Latest Ask : 28.00p |
| High Today : 28.00p | Low Today : 25.16p |
| This Years High : 67.50p | This Years Low : 10.25p |
| Volume : 115,821 | MKT Cap : £35M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
Sareum Holdings (SAR) Overview
Sareum discovers and develops innovative drug candidates aimed at cancers and autoimmune diseases. Our drug development programmes aim to improve outcomes for patients with serious medical conditions and where current therapies are inadequate.Sareum Holdings (SAR) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Buy | Peel Hunt | Premium Only | 2023-06-06 14:15:00 06/06/2023 | -82.14% |
| Long Term Buy | Royston Wild | Premium Only | 2021-08-22 07:55:00 22/08/2021 | -92.27% |
| Sell | Gary Newman | Premium Only | 2016-03-14 08:56:04 14/03/2016 | -15.25% |
Sareum Holdings (SAR) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 25.00p | Latest Ask : 28.00p |
| High Today : 28.00p | Low Today : 25.16p |
| This Years High : 67.50p | This Years Low : 10.25p |
| Volume : 115,821 | MKT Cap : £35M |
Sareum Holdings Overview
Sareum discovers and develops innovative drug candidates aimed at cancers and autoimmune diseases. Our drug development programmes aim to improve outcomes for patients with serious medical conditions and where current therapies are inadequate.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest Sareum Holdings Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Buy | Peel Hunt | Premium Only | 2023-06-06 14:15:00 06/06/2023 | -82.14% |
| Long Term Buy | Royston Wild | Premium Only | 2021-08-22 07:55:00 22/08/2021 | -92.27% |
| Sell | Gary Newman | Premium Only | 2016-03-14 08:56:04 14/03/2016 | -15.25% |